Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Lymphomatoid Granulomatosis
NCT00001379Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 1995
- Primary completion
- Jan 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in lymphomatoid granulomatosis (LYG), sponsored by National Cancer Institute. Started May 1995; status: completed.
02
Drugs
interferon alfa
03
Conditions
lymphomatoid granulomatosis (LYG)
Beyond the preview
Go deeper on NCT00001379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001379.